Reaction
Application Site Acne reporting signals
As of the last recalculation, Application Site Acne appears in 471 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is MINOXIDIL (PRR 197.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Minoxidil | 141 | 197.5 | 198.2 |
| Minoxidil Foam 5% (Womens) | 106 | 182.9 | 183.5 |
| Tretinoin | 5 | 27.5 | 27.5 |
| Ruxolitinib | 30 | 19.7 | 19.7 |
| Crisaborole | 3 | 13.9 | 13.9 |
| Salicylic Acid | 5 | 4.2 | 4.2 |
| Adapalene | 3 | 0.7 | 0.7 |